The US Food and Drug Administration has approved a new HIV-prevention medication called Yeztugo. The drug nearly eliminated the spread of HIV in clinical trials.
It is the first in a new class of antiretrovirals that block HIV from infecting and making new copies of itself inside the immune cells it targets.
It costs $14,109 per injection, so health insurers will likely decline to cover the treatment in favor of other forms of PrEP, which can cost as little as $30 per month.
Read the article on nbcnews.com.
Sources:
• TLDR. (2025, June 20). TLDR Newsletter. https://a.tldrnewsletter.com/web-version?ep=1&lc=f5cb7e17-003d-11ed-9258-0241b9615763&p=3ff15ee2-4dad-11f0-8a0a-0bdfefe0127d&pt=campaign&t=1750416976&s=64bf54165cbacd5282266e883d964a07f581266b3d17c910203228b42356c048
• FDA approves powerful new HIV drug. (2025, June 19). [Video]. NBC News. https://www.nbcnews.com/health/health-news/fda-hiv-prevention-drug-prep-lenacapavir-rcna208387